Article by Dana P. Goldman, Karen Van Nuys, Wei-Han Cheng, Jakub P. Hlávka, Luca Pani, Sylvain Chassang & Erik Snowberg
Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.
Insights Report by NEJM Catalyst & University of Utah Health
Article by Michael Nurok, Thoralf Sundt & Bruce Gewertz
In a value-based world, the sickest patients need the benefit of a comprehensive team to provide evidence-based treatment that will deliver desirable clinical outcomes while optimizing the cost of care.
Navigating risk. Embracing reform.
Strategies. Stories. Solutions.
Targeting barriers. Achieving real change.
Coordination. Integration. Reinvention.
Cedars-Sinai Medical Center
January 31, 2019